Erste Asset Management GmbH Raises Stake in Agilent Technologies, Inc. $A

Erste Asset Management GmbH raised its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 3.7% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 119,272 shares of the medical research company’s stock after buying an additional 4,210 shares during the quarter. Erste Asset Management GmbH’s holdings in Agilent Technologies were worth $15,309,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Resona Asset Management Co. Ltd. boosted its position in shares of Agilent Technologies by 6.2% in the second quarter. Resona Asset Management Co. Ltd. now owns 98,400 shares of the medical research company’s stock valued at $11,631,000 after acquiring an additional 5,767 shares during the period. CCLA Investment Management grew its position in Agilent Technologies by 10.5% during the third quarter. CCLA Investment Management now owns 1,027,970 shares of the medical research company’s stock worth $131,909,000 after buying an additional 97,312 shares in the last quarter. Envestnet Asset Management Inc. increased its stake in Agilent Technologies by 3.8% in the 3rd quarter. Envestnet Asset Management Inc. now owns 607,914 shares of the medical research company’s stock worth $78,026,000 after acquiring an additional 22,498 shares during the last quarter. Nuance Investments LLC increased its stake in Agilent Technologies by 13.5% in the 2nd quarter. Nuance Investments LLC now owns 80,698 shares of the medical research company’s stock worth $9,523,000 after acquiring an additional 9,628 shares during the last quarter. Finally, Osaic Holdings Inc. raised its holdings in shares of Agilent Technologies by 35.5% in the 2nd quarter. Osaic Holdings Inc. now owns 68,053 shares of the medical research company’s stock valued at $8,017,000 after acquiring an additional 17,817 shares in the last quarter.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Evercore upgraded shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and upped their price objective for the stock from $155.00 to $160.00 in a research report on Monday, January 5th. HSBC started coverage on shares of Agilent Technologies in a research report on Tuesday, January 20th. They set a “buy” rating and a $180.00 target price for the company. Wells Fargo & Company decreased their price target on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a report on Thursday. Barclays lowered their price objective on shares of Agilent Technologies from $165.00 to $150.00 and set an “overweight” rating on the stock in a research report on Thursday. Finally, Bank of America upped their target price on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 25th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $161.29.

Agilent Technologies Price Performance

A stock opened at $121.08 on Friday. The firm has a market cap of $34.25 billion, a P/E ratio of 26.73, a P/E/G ratio of 3.51 and a beta of 1.30. The firm’s fifty day moving average is $134.67 and its 200 day moving average is $135.91. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $160.27. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.52 and a current ratio of 1.96.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing the consensus estimate of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.95% and a net margin of 18.26%.The business had revenue of $1.80 billion during the quarter, compared to the consensus estimate of $1.81 billion. During the same period in the prior year, the firm earned $1.31 earnings per share. The business’s revenue for the quarter was up 7.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Research analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 22nd. Investors of record on Tuesday, March 31st will be given a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a yield of 0.8%. The ex-dividend date is Tuesday, March 31st. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.52%.

Agilent Technologies News Roundup

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Management raised FY‑2026 revenue ambition to $7.3B–$7.5B and highlighted expansion of its Ignite operating system as a path to future margin improvement. Read More.
• Positive Sentiment: Most sell‑side firms remain constructive (buy/overweight) and retain multi‑quarter price targets well above the current level despite trimming targets this week — supporting medium‑term upside if growth/margins recover. Read More.
• Neutral Sentiment: Agilent issued Q2 FY2026 EPS guidance of $1.39–1.42 and FY EPS of $5.90–6.04, which sits roughly around Street expectations — guidance is not a major beat or miss. Read More.
• Neutral Sentiment: Q4/CY2025 results were reported in line with expectations earlier, so the current reaction is focused on Q1 specifics and forward execution rather than a broader trend break. Read More.
• Negative Sentiment: Q1 results narrowly missed: EPS $1.36 vs. $1.37 consensus and revenue ~$1.80B vs. ~$1.81–1.84B estimates — the miss (and a weak margin cadence) triggered a near‑term selloff in earnings reaction. Read More.
• Negative Sentiment: Management said a severe U.S. winter storm disrupted shipments and service in the quarter, pressuring near‑term revenue and gross margins — investors may see this as a risk to near‑term execution. Read More.
• Negative Sentiment: Operating profit and operating cash flow declined year‑over‑year (cash from operations down notably), which raises short‑term concerns about margin leverage and free‑cash‑flow conversion. Institutional trimming noted in recent filings adds to near‑term selling pressure. Read More.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.